Table 2 Clinical and histologic characteristics by tumor stage.
T1 tumors | T2 and above tumors | |||||
|---|---|---|---|---|---|---|
SCC with basaloid features n = 13 | Conventional SCC n = 19 | p | SCC with basaloid features n = 9 | Conventional SCC n = 19 | p | |
Age | 68.5(56–79) | 65.7(47–85) | 0.43 | 66.6(53–82) | 71(51–83) | 0.21 |
Gender | Male: 7 | Male: 11 | 0.83 | Male: 7 | Male: 8 | 0.11 |
Female: 6 | Female: 8 | Female: 2 | Female: 11 | |||
Tumor location | Upper/mid: 8 | Upper/mid: 8 | 0.295 | Upper/mid: 3 | Upper/mid:11 | 0.42 |
Lower: 5 | Lower: 11 | Lower: 6 | Lower: 8 | |||
Tumor size (cm) | 2.1 (0.3–3.8) | 2.65 (0.5–9.5) | 0.45 | 3.08 (1.7–5.3) | 4.3 (1.9–11) | 0.15 |
Lymph node status | Positive: 2 | Positive: 0 | 0.038* | Positive: 4 | Positive: 6 | 0.67 |
Negative: 11 | Negative:19 | Negative: 5 | Negative: 13 | |||
Associated with diffuse or multifocal dysplasia | Positive: 6 | Positive: 1 | 0.01* | Positive: 6 | Positive: 0 | <0.001* |
Negative: 7 | Negative: 18 | Negative: 3 | Negative: 19 | |||
Survival rate (80 months) | 70% | 80% | 0.54 | 20% | 20% | 0.73 |
